• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PPM1D 及其他 9 个种系共享改变在一个家族中的病例研究。

A Case Study on PPM1D and 9 Other Shared Germline Alterations in a Family.

机构信息

Institute of Science, Nirma University, Ahmadabad, Gujarat India.

Institute of Technology, Nirma University, Gujarat India.

出版信息

Asian Pac J Cancer Prev. 2023 Jun 1;24(6):2129-2134. doi: 10.31557/APJCP.2023.24.6.2129.

DOI:10.31557/APJCP.2023.24.6.2129
PMID:37378944
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10505862/
Abstract

BACKGROUND

The use of high-throughput genotyping techniques has enabled us to identify the rare germline genetic variants with different pathogenicity and penetrance, and understand their role in cancer predisposition. We report here a familial cancer case, a study from Western Indian.

METHODS

NGS-WES was carried out in a lung cancer patient who has a family history of multiple cancers across generations, including tongue, lung, brain, cervical, urothelial, and esophageal cancer. The results were validated by data mining from available data bases. I-TASSER, RasMol and PyMol were used for protein structure modelling.

RESULTS

The sequencing by NGS-WES revealed PPM1D c.1654C>T (p.Arg552Ter) mutation in hotspot region exon 6 leading to sudden protein truncation and loss of the C-terminal, due to the substitution of C>T. This mutation was classified as a variant of uncertain significance (VUS), due to limited data on lung cancer, The three unaffected siblings of proband did not show any pathogenic variants and comparative analysis of the four siblings indicate 9 shared genetic variants, classified as benign as per ClinVar.

CONCLUSION

PPM1D constitutional genetic alterations are rare and uncommon in different ethnic populations. This gene encodes a phosphatase playing role in regulating the P53 tumor suppressor pathway and DNA damage response. Genetic alterations in the PPM1D gene maybe linked to history of gliomas, breast cancer, and ovarian cancer onset in the proband's family.
.

摘要

背景

高通量基因分型技术的应用使我们能够识别具有不同致病性和外显率的罕见种系遗传变异体,并了解它们在癌症易感性中的作用。我们在这里报告一个来自印度西部的家族性癌症病例研究。

方法

对一名有跨代多种癌症家族史(包括舌、肺、脑、宫颈、尿路上皮和食管)的肺癌患者进行 NGS-WES 检测。结果通过挖掘现有数据库进行验证。使用 I-TASSER、RasMol 和 PyMol 进行蛋白质结构建模。

结果

NGS-WES 测序显示 PPM1D c.1654C>T(p.Arg552Ter)突变位于热点区域外显子 6 中,导致 C>T 取代导致蛋白质截短和 C 端丢失。由于肺癌相关数据有限,该突变被归类为意义未明的变异体(VUS)。先证者的 3 名无血缘关系的兄弟姐妹均未显示任何致病性变异体,对 4 名兄弟姐妹的比较分析表明有 9 个共享的遗传变异体,根据 ClinVar 被归类为良性。

结论

PPM1D 种系遗传改变在不同种族人群中罕见且不常见。该基因编码一种磷酸酶,在调节 P53 肿瘤抑制途径和 DNA 损伤反应中发挥作用。PPM1D 基因突变可能与先证者家族中的神经胶质瘤、乳腺癌和卵巢癌发病史有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9477/10505862/91ef13e2880d/APJCP-24-2129-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9477/10505862/a6d297883df4/APJCP-24-2129-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9477/10505862/961c3f4da796/APJCP-24-2129-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9477/10505862/d420887af11a/APJCP-24-2129-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9477/10505862/91ef13e2880d/APJCP-24-2129-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9477/10505862/a6d297883df4/APJCP-24-2129-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9477/10505862/961c3f4da796/APJCP-24-2129-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9477/10505862/d420887af11a/APJCP-24-2129-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9477/10505862/91ef13e2880d/APJCP-24-2129-g004.jpg

相似文献

1
A Case Study on PPM1D and 9 Other Shared Germline Alterations in a Family.PPM1D 及其他 9 个种系共享改变在一个家族中的病例研究。
Asian Pac J Cancer Prev. 2023 Jun 1;24(6):2129-2134. doi: 10.31557/APJCP.2023.24.6.2129.
2
Mosaic PPM1D mutations are associated with predisposition to breast and ovarian cancer.马赛克 PPM1D 突变与乳腺癌和卵巢癌的易感性有关。
Nature. 2013 Jan 17;493(7432):406-10. doi: 10.1038/nature11725. Epub 2012 Dec 16.
3
Landscape of germline pathogenic variants in patients with dual primary breast and lung cancer.双原发乳腺癌和肺癌患者种系致病性变异的全景。
Hum Genomics. 2023 Jul 17;17(1):66. doi: 10.1186/s40246-023-00510-7.
4
Detectible mosaic truncating PPM1D mutations, age and breast cancer risk.可检测到镶嵌性截短 PPM1D 突变、年龄与乳腺癌风险。
J Hum Genet. 2019 Jun;64(6):545-550. doi: 10.1038/s10038-019-0589-1. Epub 2019 Mar 8.
5
Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals.在高危芬兰 BRCA1/2 种系突变阴性的乳腺癌和/或卵巢癌个体中筛查 BRCA1、BRCA2、CHEK2、PALB2、BRIP1、RAD50 和 CDH1 突变。
Breast Cancer Res. 2011 Feb 28;13(1):R20. doi: 10.1186/bcr2832.
6
Truncating mutations of PPM1D are found in blood DNA samples of lung cancer patients.在肺癌患者的血液DNA样本中发现了PPM1D的截短突变。
Br J Cancer. 2015 Mar 17;112(6):1114-20. doi: 10.1038/bjc.2015.79.
7
Somatic mosaic truncating mutations of PPM1D in blood can result from expansion of a mutant clone under selective pressure of chemotherapy.血液中 PPM1D 的体细胞镶嵌截断突变可源于在化疗的选择压力下突变克隆的扩增。
PLoS One. 2019 Jun 26;14(6):e0217521. doi: 10.1371/journal.pone.0217521. eCollection 2019.
8
Novel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from India.印度乳腺癌患者中乳腺癌易感基因BRCA1、BRCA2和p53基因的新型种系突变。
Breast Cancer Res Treat. 2004 Nov;88(2):177-86. doi: 10.1007/s10549-004-0593-8.
9
Mutations in BRCA-related breast and ovarian cancer in the South African Indian population: A descriptive study.BRCA 相关的乳腺癌和卵巢癌在南非印度人群中的突变:一项描述性研究。
Cancer Genet. 2021 Nov;258-259:1-6. doi: 10.1016/j.cancergen.2021.06.002. Epub 2021 Jun 15.
10
Prevalence and spectrum of BRCA germline variants in mainland Chinese familial breast and ovarian cancer patients.中国大陆家族性乳腺癌和卵巢癌患者中BRCA种系变异的患病率及谱系
Oncotarget. 2016 Feb 23;7(8):9600-12. doi: 10.18632/oncotarget.7144.

本文引用的文献

1
PPM1D mutations are oncogenic drivers of de novo diffuse midline glioma formation.PPM1D 突变是新发弥漫性中线胶质瘤形成的致癌驱动因素。
Nat Commun. 2022 Feb 1;13(1):604. doi: 10.1038/s41467-022-28198-8.
2
Strong Correlation of MTHFR Gene Polymorphisms with Breast Cancer and its Prognostic Clinical Factors among Egyptian Females.埃及女性中MTHFR基因多态性与乳腺癌及其预后临床因素的强相关性。
Asian Pac J Cancer Prev. 2021 Feb 1;22(2):617-626. doi: 10.31557/APJCP.2021.22.2.617.
3
Protein phosphatase, Mg/Mn-dependent 1D (PPM1D) mutations in haematological cancer.
蛋白磷酸酶,Mg/Mn 依赖性 1D(PPM1D)突变与血液系统恶性肿瘤。
Br J Haematol. 2021 Feb;192(4):697-705. doi: 10.1111/bjh.17120. Epub 2020 Dec 8.
4
Influence of single nucleotide polymorphisms among cigarette smoking and non-smoking patients with coronary artery disease, urinary bladder cancer and lung cancer.在患有冠心病、膀胱癌和肺癌的吸烟和不吸烟患者中,单核苷酸多态性的影响。
PLoS One. 2021 Jan 28;16(1):e0243084. doi: 10.1371/journal.pone.0243084. eCollection 2021.
5
Next-Generation Sequencing at High Sequencing Depth as a Tool to Study the Evolution of Metastasis Driven by Genetic Change Events of Lung Squamous Cell Carcinoma.高测序深度的下一代测序作为研究肺鳞状细胞癌基因改变事件驱动的转移演变的工具
Front Oncol. 2020 Aug 5;10:1215. doi: 10.3389/fonc.2020.01215. eCollection 2020.
6
High-Throughput Sequencing of Gastric Cancer Patients: Unravelling Genetic Predispositions Towards an Early-Onset Subtype.胃癌患者的高通量测序:揭示早发型亚型的遗传易感性
Cancers (Basel). 2020 Jul 21;12(7):1981. doi: 10.3390/cancers12071981.
7
Methylenetetrahydrofolate reductase gene polymorphisms in the risk of polycystic ovary syndrome and ovarian cancer.亚甲基四氢叶酸还原酶基因多态性与多囊卵巢综合征和卵巢癌的风险。
Biosci Rep. 2020 Jul 31;40(7). doi: 10.1042/BSR20200995.
8
A Study of Ser217Leu and Ala541Thr Polymorphism in the Men Afflicted with Prostate Cancer and in the Men being Suspicious of Prostate Cancer.前列腺癌患者与可疑前列腺癌患者中 Ser217Leu 和 Ala541Thr 多态性的研究。
Asian Pac J Cancer Prev. 2020 Jun 1;21(6):1551-1557. doi: 10.31557/APJCP.2020.21.6.1551.
9
TP53 Arg72Pro polymorphism and neuroblastoma susceptibility in eastern Chinese children: a three-center case-control study.TP53 Arg72Pro 多态性与中国东部儿童神经母细胞瘤易感性的相关性:一项三中心病例对照研究。
Biosci Rep. 2020 May 29;40(5). doi: 10.1042/BSR20200854.
10
The role of PPM1D in cancer and advances in studies of its inhibitors.PPM1D 在癌症中的作用及其抑制剂研究进展。
Biomed Pharmacother. 2020 May;125:109956. doi: 10.1016/j.biopha.2020.109956. Epub 2020 Jan 29.